Navigation Links
PETA International Science Consortium disappointed in denial of Dow appeal
Date:6/19/2013

The PETA International Science Consortium (PISC) is extremely disappointed that the European Chemicals Agency (ECHA) Board of Appeal has upheld a decision that requires Dow Benelux B.V.to conduct a pre-natal developmental toxicity study in rats. The study will use approximately 1160 animals and expose pregnant rats and their unborn pups to the substance dipropylene glycol methyl ether acetate (DPMA) in order to comply with the European Community's Regulation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).

PISC urges the Board of Appeal to demonstrate greater independence when making decisions regarding the justification of read-across arguments in future appeal cases.

The substance DPMA hydrolyses to dipropylene glycol methyl ether (DPM), for which data are already available. In an appeal filed on January 24, 2012, the company rightfully argued that the testing requirement was, therefore, satisfied using read-across arguments.

The Board of Appeal's decision means that pregnant rats will be forced to consume high concentrations of the chemical over a 16 day period before being killed and their offspring, dissected. Read-across arguments are a mechanism by which large numbers of animal tests can be avoided which makes this decision even more disappointing as it may unjustifiably discourage other chemical manufacturers from using valid read-across arguments which could ultimately lead to hundreds of thousands of additional animals being used. As many as ten million animals could be used in testing conducted for REACH.

The European Ombudsman is currently considering a complaint submitted by PETA in July 2012 alleging that ECHA is failing to ensure that animal testing is conducted only as a "last resort," as required by the REACH regulation.


'/>"/>

Contact: Gilly Stoddart
GillyS@peta.org.uk
44-207-837-6327
People for the Ethical Treatment of Animals
Source:Eurekalert

Page: 1

Related biology news :

1. First international collaboration to showcase latest body of evidence of dairy health benefits
2. SPIE on global team proposing International Year of Light at United Nations
3. CLEO: 2013 -- the Premier International Laser and Electro-Optics Event in San Jose next week
4. New review sets international standards for best practice in fracture liaison services
5. BGI hosts its 2nd International Conference on Genomics in the Americas
6. Drive-Up Biometric System from SRI International Sarnoff Wins New Product Showcase Award at ISC West 2013
7. International conference will put agri-food supply chain under the microscope
8. International collaboration to investigate disappearing reptiles and amphibians
9. International conference to tackle climate-change threats to agriculture
10. International study: Excess dietary salt may drive the development of autoimmune diseases
11. International consortium builds Google Map of human metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Analysis & Trends - Industry Forecast to 2025" report to ... The ... a CAGR of around 15.1% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
Breaking Biology News(10 mins):
(Date:4/21/2017)... ... April 21, 2017 , ... Frederick Innovative Technology Center, Inc. ... bio and technology start-ups, is hosting “Celebration Friday” (a festive gathering highlighting client ... with libations and networking at 3:30 p.m. at FITCI’s 4539 Metropolitan Court location, ...
(Date:4/20/2017)... ... April 20, 2017 , ... As part of ... explore challenging patient cases when screening for direct oral anticoagulant. When patients taking ... need for bridging parental anticoagulation especially for those at high risk of thrombosis ...
(Date:4/20/2017)... 20, 2017  Eli Lilly and Company (NYSE: ... galcanezumab for the prevention of migraine at the American ... place April 22-28, 2017, in Boston ... at AAN, including safety and patient outcomes data for ... a reduction in monthly migraine headache days among patients ...
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... ... to the scientific and clinical research community’s growing body of knowledge during its ... in the Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, ...
Breaking Biology Technology: